These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22683521)

  • 1. Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries.
    Beurret M; Hamidi A; Kreeftenberg H
    Vaccine; 2012 Jul; 30(33):4897-906. PubMed ID: 22683521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to emerging vaccine manufacturers.
    Hamidi A; Boog C; Jadhav S; Kreeftenberg H
    Vaccine; 2014 Jul; 32(33):4124-30. PubMed ID: 24923635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transfer.
    Hamidi A; Verdijk P; Kreeftenberg H
    Hum Vaccin Immunother; 2014; 10(9):2691-6. PubMed ID: 25483504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of immuno assays during the development of a Hemophilus influenzae type b vaccine for technology transfer to emerging vaccine manufacturers.
    Hamidi A; Kreeftenberg H
    Hum Vaccin Immunother; 2014; 10(9):2697-703. PubMed ID: 25483494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process development of a New Haemophilus influenzae type b conjugate vaccine and the use of mathematical modeling to identify process optimization possibilities.
    Hamidi A; Kreeftenberg H; V D Pol L; Ghimire S; V D Wielen LA; Ottens M
    Biotechnol Prog; 2016 May; 32(3):568-80. PubMed ID: 26821825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
    Eskola J
    J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.
    Gessner BD
    Expert Rev Vaccines; 2009 Jan; 8(1):91-102. PubMed ID: 19093776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.
    Breukels MA; Spanjaard L; Sanders LA; Rijkers GT
    Clin Infect Dis; 2001 Jun; 32(12):1700-5. PubMed ID: 11360210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Haemophilus influenzae Type b conjugate vaccine in Mongolia: prospective population-based surveillance, 2002-2010.
    Scott S; Altanseseg D; Sodbayer D; Nymadawa P; Bulgan D; Mendsaikhan J; Watt JP; Slack MP; Carvalho MG; Hajjeh R; Edmond KM
    J Pediatr; 2013 Jul; 163(1 Suppl):S8-S11. PubMed ID: 23773599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
    Jadhav S; Datla M; Kreeftenberg H; Hendriks J
    Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda.
    Muganga N; Uwimana J; Fidele N; Gahimbare L; Gessner BD; Mueller JE; Mhlanga BR; Katsande R; Herbinger KH; Rugambwa C
    Vaccine; 2007 Sep; 25(39-40):7001-5. PubMed ID: 17709159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of haemophilus influenzae type B conjugate vaccine for prevention of meningitis in Senegal.
    Fleming JA; Dieye Y; Ba O; Mutombo wa Mutombo B; Diallo N; Faye PC; Ba M; Cisse MF; Diallo AG; Ba M; Slack MP; Weiss NS
    Pediatr Infect Dis J; 2011 May; 30(5):430-2. PubMed ID: 21099444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forecasting demand for Hib-containing vaccine in the world's poorest countries: a 4-year prospective experience.
    Zuber PL; Dumolard L; Shirey M; Rizzo I; Marshall J
    Vaccine; 2009 Jan; 27(3):410-5. PubMed ID: 19013493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries.
    Garcia S; Lagos R; Muñoz A; Picón T; Rosa R; Alfonso A; Abriata G; Gentile A; Romanin V; Regueira M; Chiavetta L; Agudelo CI; Castañeda E; De la Hoz F; Higuera AB; Arce P; Cohen AL; Verani J; Zuber P; Gabastou JM; Pastor D; Flannery B; Andrus J
    Vaccine; 2012 Jan; 30(2):486-92. PubMed ID: 22085550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
    Ribeiro GS; Lima JB; Reis JN; Gouveia EL; Cordeiro SM; Lobo TS; Pinheiro RM; Ribeiro CT; Neves AB; Salgado K; Silva HR; Reis MG; Ko AI
    Vaccine; 2007 May; 25(22):4420-8. PubMed ID: 17449150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.